{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Aerosol-generating procedures",
      "Infectivity",
      "Nosocomial infection",
      "SARS-CoV-2",
      "Transmission"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32497651",
  "DateCompleted": {
    "Year": "2020",
    "Month": "08",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "06",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jhin.2020.05.037",
      "S0195-6701(20)30277-2"
    ],
    "Journal": {
      "ISSN": "1532-2939",
      "JournalIssue": {
        "Volume": "105",
        "Issue": "4",
        "PubDate": {
          "Year": "2020",
          "Month": "Aug"
        }
      },
      "Title": "The Journal of hospital infection",
      "ISOAbbreviation": "J Hosp Infect"
    },
    "ArticleTitle": "Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence.",
    "Pagination": {
      "StartPage": "717",
      "EndPage": "725",
      "MedlinePgn": "717-725"
    },
    "Abstract": {
      "AbstractText": [
        "The transmission behaviour of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still being defined. It is likely that it is transmitted predominantly by droplets and direct contact and it is possible that there is at least opportunistic airborne transmission. In order to protect healthcare staff adequately it is necessary that we establish whether aerosol-generating procedures (AGPs) increase the risk of transmission of SARS-CoV-2. Where we do not have evidence relating to SARS-CoV-2, guidelines for safely conducting these procedures should consider the risk of transmitting related pathogens. Currently there is very little evidence detailing the transmission of SARS-CoV-2 associated with any specific procedures. Regarding AGPs and respiratory pathogens in general, there is still a large knowledge gap that will leave clinicians unsure of the risk to themselves when offering these procedures. This review aimed to summarize the evidence (and gaps in evidence) around AGPs and SARS-CoV-2."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 The Healthcare Infection Society. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sunshine Coast Hospital and Health Service, Queensland, Australia. Electronic address: henry.harding@health.qld.gov.au."
          }
        ],
        "LastName": "Harding",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Social and Political Sciences, The University of Sydney, New South Wales, Australia."
          }
        ],
        "LastName": "Broom",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sunshine Coast Health Institute, Queensland, Australia; University of Queensland, Brisbane, Australia."
          }
        ],
        "LastName": "Broom",
        "ForeName": "J",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Hosp Infect",
    "NlmUniqueID": "8007166",
    "ISSNLinking": "0195-6701"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Aerosols"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Middle East Afr J Ophthalmol. 2020 Jul 20;27(2):69-72",
      "PMID": "32874037"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aerosols"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Betacoronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "diagnosis",
        "transmission"
      ],
      "DescriptorName": "Coronavirus Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Health Personnel"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Infectious Disease Transmission, Patient-to-Professional"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Occupational Exposure"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "diagnosis",
        "transmission"
      ],
      "DescriptorName": "Pneumonia, Viral"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Risk Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}